The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-7 of 7 articles
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I,
Dumonteil N,
Blackman D,
Tchetché D,
Walters D,
Hildick-Smith D,
Manoharan G,
Harnek J,
Worthley S,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem N,
Feldman T,
Allocco D,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N,
Meredith I,
Blackman D,
Tchetché D,
Hildick-Smith D,
Spence M,
Walters D,
Harnek J,
Worthley S,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem N,
Houle V,
Allocco D,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry
Malkin C,
Long W,
Baxter P,
Gale C,
Wendler O,
Monaghan M,
Thomas M,
Ludman P,
De Belder M,
Cunningham A,
Moat N,
Blackman D
February 19, 2016 | 10.4244/EIJY14M12_12
Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population
Shelton R,
Eftychiou C,
Somers K,
Liu A,
Burton-Wood N,
Anderson M,
Makri L,
Blaxill J,
McLenachan J,
Wheatcroft S,
Greenwood J,
Blackman D
May 21, 2013 | 10.4244/EIJV9I1A17
Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design
Kelly D,
McCann G,
Blackman D,
Curzen N,
Dalby M,
Greenwood J,
Fairbrother K,
Shipley L,
Kelion A,
Heatherington S,
Khan J,
Nazir S,
Alahmar A,
Flather M,
Swanton H,
Schofield P,
Gunning M,
Hall R,
Gershlick A
February 22, 2013 | 10.4244/EIJV8I10A183
Complications of transcatheter aortic valve implantation: avoidance and management
Hildick-Smith D,
Redwood S,
Mullen M,
Thomas M,
Kovac J,
Brecker S,
Trivedi U,
Young C,
Hutchinson N,
MacCarthy P,
Prendergast B,
De Belder M,
Monaghan M,
Blackman D,
Baumbach A,
Manoharan G,
Moat N
September 30, 2011 | 10.4244/EIJV7I5A99
Latest news
NEW ISSUE
Part 2 of the consensus document of the European Bifurcation Club; one-month DAPT after PCI depending on clinical presentation; ARC high bleeding risk criteria and TAVI; and more
August 19, 2022
AHEAD OF PRINT
Ticagrelor monotherapy in PCI patients with prior CABG: the TWILIGHT-CABG study
FREE ARTICLE - Gennaro Sardella et al
August 18, 2022
AHEAD OF PRINT
First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system
FREE ARTICLE - Emmanuel Teiger et al
August 16, 2022
AHEAD OF PRINT
Extracardiac basal annuloplasty for the treatment of secondary mitral regurgitation
FREE ARTICLE - Jérémy Bernard et al
August 11, 2022
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022